Lactulose Fresenius (Lactulose, Liquid)

Lactulose is a synthetic sugar that reaches the colon unchanged, where intestinal bacteria ferment it into short‑chain fatty acids. This creates an osmotic effect that softens stool, promotes bowel movements, and acidifies the colonic environment, which helps lower blood ammonia levels.

The prescribed dose of Lactulose Fresenius is individualized by the treating physician based on the patient’s age, condition, and response. Dosage may be adjusted to achieve the desired clinical effect while minimizing side effects.

Safety data for lactulose in pregnancy and lactation are limited. It should be used only if the potential benefit justifies any possible risk to the fetus or infant, and the decision should be made by the prescribing healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Unlike stimulant laxatives, lactulose works by an osmotic mechanism and also reduces ammonia absorption, making it useful for hepatic encephalopathy. It is generally gentler on the bowel but may cause more gas and bloating compared with bulk‑forming agents.

Lactulose Fresenius should be stored at room temperature, below 25 °C, in its original container. Protect the solution from moisture, direct sunlight and extreme temperatures to maintain stability.

The medication is taken orally as a liquid solution. It can be measured with a calibrated dosing device and mixed with water or another suitable liquid if needed, following the prescribing clinician’s instructions.

Serious risks include severe electrolyte disturbances, marked dehydration, and rare allergic reactions. Patients should be monitored for signs of dehydration, abnormal heart rhythm, or severe abdominal pain, especially if large volumes are taken.

Lactulose is contraindicated in individuals with known hypersensitivity to lactulose, as well as patients with intestinal obstruction, perforation, or severe inflammatory bowel disease where increased bowel motility could be harmful.